The symposia of excellence
Since 1973 the World Symposium on Pulmonary Hypertension harmonizes research progresses on pulmonary hypertension.
Dear Colleagues,
We are pleased to inform you that the next 7th World Symposium on Pulmonary Hypertension (7th WSPH) will take place in Barcelona, Spain, from Saturday June 29th to Monday July 1st 2024.
Traditionally, the PH World Symposia series, initiated in Geneva in 1973 and held every 5 years after the Evian edition in 1998 (Venice 2003, Dana Point 2008, Nice 2013, Nice 2018), has marked the progress in pulmonary hypertension science and has identified fruitful directions for future developments. The published supplements, including the symposia proceedings, constitute a collection of articles among the most cited in this scientific area.
Each new edition of the WSPH series has experienced an increase in attendance, signifying the growing interest of this field’s stakeholders. More than 1200 international physicians, scientists and other health care workers attended the 5th WSPH – Nice 2013, and more than 1500 attended the 6th WSPH – Nice 2018.
The objectives of the 7th WSPH will be as follows:
- Review by expert task forces of the major advances in pulmonary vascular science over the past 6 years
- Analysis of the available evidence in basic and clinical areas
- Identification of the evidence gaps in different areas, and proposals for future collaborative research programs
- Production of documents by the task forces that summarize the results of pre-symposium meetings (previous 18-24 months)
- Discussion at the symposium sessions by the task forces of documents, along with worldwide experts and with other stakeholders
- Final drafting of peer reviewed papers that will be included in a supplement in a prestigious medical journal to facilitate the dissemination of the 7th WSPH work.
15 Task Forces have been identified:
- Patient perspective
- Pathobiology and mechanisms of disease
- Genetics and genomics
- Pathophysiology of right ventricle and pulmonary vascular Interaction
- Definition, classification, and diagnosis of pulmonary hypertension
- Emerging multimodality imaging techniques of pulmonary circulation
- PAH risk stratification and treatment goals
- Transplantation and bridging, and support technologies
- PH management in special conditions
- PAH treatment algorithm
- Clinical trial designs, endpoints, and emerging therapies
- PH and left heart disease
- PH and chronic lung disease
- Chronic thromboembolic pulmonary disease
- Pediatric pulmonary hypertension
Our purpose is to foster with the Symposium constructive scientific interactions and collaborations in the field of Pulmonary Hypertension.
We look forward to meeting you in Barcelona for this important event.
The Symposium Organizing Committee
The Symposium Organizing Committee
Nazzareno Galiè
WSPHA founderHe is currently Vice-chairman of the Core Network Pulmonary Hypertension of the European Reference Network—LUNG (ERN-LUNG) under the aegis of the European Commission. He is also coordinator of the Guidelines and best Practice of Care committee of ERN-LUNG. Nazzareno Galiè authored 264 cited publications on heart failure, pulmonary thromboembolic disease and pulmonary hypertension. The SCOPUS H-index is 74. Prof. Galiè has been included in the Thomson Reuters Highly Cited Researchers list in 2014 and 2016 and in the Clarivate Analytics Highly Cited Researchers list in 2017 and 2018.
Vallerie Victoria McLaughlin
WSPHA founderProf. McLaughlin is an editorial board member of Chest, a Guest Editor for the Journal of the American College of Cardiology and past Editor-in-Chief of Advances in Pulmonary Hypertension. She is a past Chair of the Scientific Leadership Committee and past Chair of the Board of Trustees of the Pulmonary Hypertension Association, she chaired the American College of Cardiology Foundation/AHA Clinical Expert Consensus Document Committee for Pulmonary Arterial Hypertension and is Co-Principal Investigator of the Pulmonary Hypertension Breakthrough Initiative and Education Fund Steering Committee. She is Topic Working Group Coordinator for the Pulmonary Hypertension Pathway for the American College of Cardiology Annual Scientific Sessions. She is a two time recipient of the Alfred Soffer Research Award.
Lewis J. Rubin
WSPHA founderHe is a member of the American Society of Clinical Research, the American Heart Association, the American College of Physicians, the American College of Chest Physicians, and the American Thoracic Society. He is the recipient of the Dickinson Richards Memorial Award from the American Heart Association, the Simon Dack Award from the American College of Cardiology and the Lifetime Achievement Award from the Pulmonary Vascular Research Institute. He was listed among Thomson Reuters’ Most Influential Researchers in the World in 2014 and 2015, and received the CHEST College Medalist Award from the American College of CHEST Physicians in 2016. He also serves on the International Advisory Board for the European Respiratory Journal.
Gerald Simonneau
WSPHA founderThe first one in the New England Journal appeared more than 25 years ago and 20 articles have been published within the last year in international journals. These include the report of the French Registry for Pulmonary Hypertension in the American Journal of Respiratory and Critical Care Medicine on 700 patients with pulmonary artery hypertension referred to the French national network over a 1-year period. Prof. Simonneau earned his medical doctorate in respiratory medicine from the University Paris XII and served as a resident in respiratory and critical care medicine before assuming his academic positions. In 1998 he became Director of Unite Propre de Recherche de l’Enseignement Superieur (UPRES) on pulmonary vascular diseases.
Marc Humbert
WSPHA founderMarc Humbert, MD, PhD, is Dean and Professor of Respiratory Medicine at the Université Paris-Saclay Faculty of Medicine in Le Kremlin-Bicêtre, France. He is the Director of the Respiratory and Intensive Care Medicine Department, French Pulmonary Hypertension Reference Centre (Assistance Publique Hôpitaux de Paris). Marc Humbert is Past President of the European Respiratory Society (ERS) and he was the Chief Editor of the European Respiratory Journal from 2013 to 2017 where he is currently Section Editor in charge of Pulmonary Vascular Medicine. He has received several distinctions including the ERS Cournand Lecture Award, the Rare Disease Award of the Fondation de France and the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension. Marc is the vice-coordinator of the European Reference Network for rare and low prevalence respiratory diseases (ERN-LUNG). Clarivate Analytics has listed Marc Humbert as one of the world's highly cited researchers in the field of Clinical Medicine.
Connecting excellences
Check The Agenda
The 7th WORLD SYMPOSIUM ON PULMONARY HYPERTENSION, Barcelona, Spain 29/06/2024 - 01/07/2024 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18.5 European CME credits (ECMEC®s).
Saturday, 29 June 2024
Sunday, 30 June 2024
Monday, 1 July 2024
Endorsements
Registration fees
Fee within February 15, 2024
- 🟡POSTER PRESENTERS € 550,00
- 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL NURSES € 550,00
- 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL PHYSICIANS € 1.000,00
- 🟡NO-UNIVERSITY OR NO-PUBLIC/PRIVATE HOSPITAL PHYSICIANS AND PHARMA COMPANIES REPRESENTATIVES € 3.000,00
- 🟡REDUCED FEE FOR STAFF MEMBERS OF THE SPONSOR COMPANIES € 1.500,00
- 🟡MEMBERS OF PATIENTS ASSOCIATIONS** € 550,00
Registration Fees (VAT included)
After February 15, 2024
- 🟡POSTER PRESENTERS € 550,00
- 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL NURSES € 550,00
- 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL PHYSICIANS € 1.300,00
- 🟡NO-UNIVERSITY OR NO-PUBLIC/PRIVATE HOSPITAL PHYSICIANS AND PHARMA COMPANIES REPRESENTATIVES € 3.400,00
- 🟡REDUCED FEE FOR STAFF MEMBERS OF THE SPONSOR COMPANIES € 1.750,00
- 🟡MEMBERS OF PATIENTS ASSOCIATIONS** € 550,00
Registration Fees (VAT included)
Timeline
Abstract submissionJanuary 9 January 17, 2024
Communication of acceptance of abstracts
January 31, 2024
Early bird registrations
February 15, 2024
Deadline for refund requests for registrations
May 20, 2024
Online registrations open until
June 20, 2024
No refund will be provided for any cancellation including no-shows
from May 21, 2024
International Barcelona Convention Center ENTRANCE B
Get Direction to the Event Hall
Barcelona is one of the great urban, economic and business centres of Europe, with several connections around the world. The Catalan capital has turned innovation, technological and scientific development, design, commerce, gastronomy and quality services into core elements of its identity.
The extensive and successful experience in organising large events of all kinds and its particular and welcoming character, have made Barcelona one of the three main business tourism destinations in the world and one of the best cities in which to hold a special event.
International Barcelona Convention Center
Plaça de Willy Brandt, 11-14, 08019 Barcelona
ENTRANCE B
Convention Centre and Auditorium CCIB Forum: two connected buildings and 100,000 m² of space and infinite possibilities
The CCIB is located in the Barcelona neighbourhood of Sant Martí, in the Diagonal Mar area:
20 km to the airport
5 km to the Estació de França train station
6 km to the city centre (connected by underground or trams)
Opened in 2004 for the Universal Forum of Cultures event, the Barcelona International Convention Centre (CCIB) has become a leading European location for event organization and has hosted since then more than 1500 events.
The CCIB is made up of two architecturally stunning buildings that are linked together by an underground walkway. It has a total floor area of around 100,000 sqm and a maximum capacity of 15,000 representatives.
It has an easy access, excellent links to public transport and the airport, and more than 1.000 hotel rooms in its immediate vicinity
THE LOBBY
The lobby is the main entrance to the Convention Centre, and is a bright, dynamic space with 4 access doors that allow to divide the space if the CCIB is hosting simultaneous events.
There are also three sets of escalators that run up to the upper floors.
FIRST FLOOR_MEETING ROOM
The very best meeting rooms can be found on the P1 floor.
Foyer 1 has 5 rooms of 420 sqm and 2 with a floor space of 878 sqm. It is possible to combine all of them and all have natural light. There is also access to 2 terraces.
The flooring on the terrace is made from organic wood that uses as its base a material that comes from recycled wooden products such as sawdust and shavings
SECOND FLOOR_CATERING AND POSTERS AREA
These rooms have a total floor area of 1,248 sqm.
They enjoy natural light and have direct access to their own private terraces.
UNDERGROUND
The nearest underground station is El Maresme | Fòrum on the L4 yellow line.
It’s less than 5 minutes’ walk from the Forum exit via Rambla Prim.
Metro (TMB) https://www.tmb.cat/en/home
BUS
An extensive bus network will enable you to reach the venue from different parts of the city.
From Sants Station, H10+7 / H8+7
From Plaza Catalunya, H16
From Plaza Catalunya, line 7
Bus https://www.tmb.cat/en/barcelona-transport
TRAM
The T4 tram line runs from Ciutadella/Vila Olímpica to Sant Adrià station.
The best stop is “Fòrum”, which is located just in front of the CCB Forum Auditorium.
BY CAR/ MOTORCYCLE
Access is recommended via Taulat Street or the Diagonal Avenue, where you should look for parking in the area.
TAXI
There are two taxi ranks near the Auditorium CCIB Forum:
Taulat Street (Opposite the AC Hotel)
Josep Pla Street (Opposite the Hilton Diagonal Mar Barcelona Hotel)
AIRPORT
Josep Tarradellas Barcelona-El Prat Airport is 20 km from the CCIB. There are several transport links from the airport to the city centre: trains, underground, bus and taxi, which connect the airport with the city centre.
Josep Tarradellas Barcelona – El Prat international airport: https://www.aena.es/en/josep-tarradellas-barcelona-el-prat.html
TRAIN
Train (RENFE) https://www.renfe.com/es/en
BIKE
Bicycle sharing service https://www.tmb.cat/en/barcelona/ambici
Download Hola Barcelona APP and find the best routes, discover the places that interest you most, buy conveniently and store tickets for getting around the city.
With the non conditioning sponsorship of
SPONSORS
CVS and e4ethics ID EMT 36574
EthicalMedTech is a unique platform supported by MedTech Europe and dedicated to ethics and compliance projects in the healthcare sector. It is hosting major industry compliance initiatives – including EFPIA’s evaluation platform for European medical conferences since January 2021.
https://www.ethicalmedtech.eu/conference-vetting-system/search-events/
The Organizing Committee warmly discourages satellite symposia or any kind of meeting involving the attendees organized by industry in Barcelona before, during or after the Symposium.
